Is Creatine Safe for Diabetics to Use?

Creatine appears safe for most people with type 2 diabetes, based on the clinical trials conducted so far. No major adverse effects have been reported in randomized controlled trials involving diabetic participants, and the supplement has not been shown to damage kidney function in this population. The more interesting question, though, is whether creatine might actually help with blood sugar management, and here the evidence is genuinely promising but still thin enough that researchers hesitate to call it settled.

The Kidney Question Comes First

If you have diabetes and are considering creatine, your first concern is probably your kidneys. Diabetes is a leading cause of kidney disease, so anything that might stress the kidneys raises a red flag. Creatine’s reputation for kidney harm comes from its natural breakdown product, creatinine, which is the standard lab marker doctors use to estimate how well your kidneys are filtering. When you take creatine, your body produces more creatinine. That can make your blood test look worse even when your kidneys are working fine.

A randomized, double-blind trial specifically tested this in people with type 2 diabetes. Researchers measured kidney function using a direct clearance method rather than relying solely on creatinine-based estimates. After 12 weeks of creatine supplementation, there was no significant change in kidney filtration rate, creatinine clearance, proteinuria, or albuminuria compared to placebo.¹ That is about as reassuring as a single trial can be, though it was a small study and limited to 12 weeks.

A broader systematic review and meta-analysis pooling data from multiple creatine studies in various populations reinforced this finding. The review found that while serum creatinine levels do rise during supplementation, actual kidney filtration rates remain unchanged. The authors were clear that this creatinine bump is a predictable biochemical response to higher creatine turnover and should not be confused with kidney damage.² This distinction matters for diabetics especially, because your doctor may already be monitoring your creatinine levels closely. If you start taking creatine and your creatinine ticks up, that conversation with your doctor goes more smoothly if you both know the rise is expected and does not reflect kidney trouble.

Blood Sugar and HbA1c Findings

The most striking result from the small body of diabetes-specific creatine research is its apparent effect on hemoglobin A1c, the long-term measure of blood sugar control. In one randomized, double-blind trial of people with type 2 diabetes who were also exercising, the group taking creatine saw their HbA1c drop by about 1 percentage point compared to placebo, falling from roughly 7.4% to 6.4% over 12 weeks.³ To put that in perspective, a one-point drop in HbA1c is clinically meaningful and comparable to what some prescription diabetes medications achieve.

That said, this was a single trial with a small number of participants, and all of them were also following an exercise program. Whether creatine alone, without exercise, would produce the same HbA1c improvement in diabetic patients remains unknown. The exercise component may be essential, and teasing apart how much the creatine contributed versus the training itself is tricky.

A separate trial in sedentary healthy males found that creatine combined with aerobic training improved glucose tolerance compared to training with placebo, though it did not change fasting insulin levels.⁴ This study was not in diabetics, but it points in the same direction: creatine paired with exercise may influence how the body handles glucose in ways that go beyond what exercise alone accomplishes.

Why Creatine Might Affect Glucose at All

Creatine is best known as a fuel for short, intense muscular effort. So why would it have anything to do with blood sugar? The leading theory involves a glucose transporter called GLUT-4, a protein that acts like a door allowing sugar to enter muscle cells. Insulin normally triggers GLUT-4 to move to the cell surface and let glucose in. In type 2 diabetes, that process works poorly, so sugar builds up in the blood.

Animal research has shown that creatine feeding increases GLUT-4 protein levels in skeletal muscle, even without exercise. In one rat study, creatine supplementation boosted GLUT-4 expression along with the activity of transcription factors that regulate it.⁵ This suggests creatine may help muscle cells pull glucose out of the blood more efficiently. When you add exercise to the mix, GLUT-4 translocation increases further, which is why researchers suspect the combination of creatine and training produces stronger glucose-lowering effects than either alone.⁶

There is also evidence that creatine may stimulate insulin secretion directly, at least in isolated cells, and improve how muscles store glycogen. These are intriguing mechanisms, but most of the detailed work has been done in animals or cell cultures, not in human diabetic patients. The gap between “this looks promising in a rat” and “this works reliably in people with diabetes” is one that the field has not yet closed.

How Creatine Stacks Up Against Diabetes Medications

A systematic review of randomized clinical trials compared creatine supplementation to both placebo and common diabetes drugs. Against placebo, creatine appeared effective at lowering blood glucose and glycosylated hemoglobin. When compared to metformin or glibenclamide (a sulfonylurea), creatine performed similarly, with no significant difference between groups. All treatments reduced blood glucose, and no major adverse effects were observed in the creatine group.⁷

Before anyone considers swapping their metformin for creatine powder, this needs serious context. The number of studies was tiny, the sample sizes were small, and each trial used a different comparison group, making it hard to draw firm conclusions from the collection. Nobody in the research community is suggesting creatine replace diabetes medications. The finding is more noteworthy as a signal that creatine does something metabolically interesting in diabetic patients, not as clinical evidence that it works as well as proven drugs.

The Evidence Is Promising but Not Conclusive

A systematic review and meta-analysis that tried to quantify creatine’s overall effect on diabetes found an insufficient basis to state that creatine positively affects diabetes parameters. When the pooled data were analyzed, there was no statistically significant effect on fasting blood glucose or insulin resistance across the included studies.⁸ That sounds like it contradicts the individual trial showing a big HbA1c drop, but the meta-analysis included studies in both diabetic and non-diabetic populations, diluting the signal. The authors specifically noted that the two studies involving diabetic individuals did show benefit and called for more research focused specifically on this group.

This is where the science sits right now: individual trials in people with type 2 diabetes look encouraging, but the total body of evidence is still too small for anyone to confidently recommend creatine as a glucose-management tool. The research community treats this as a lead worth following, not a case closed. Combined exercise and creatine supplementation do show potential for improving glucose regulation and slowing age-related muscle loss in older adults and people with type 2 diabetes, but more and larger trials are needed.⁹

Practical Considerations if You Have Diabetes

If you decide to try creatine, a few practical points are worth knowing. The standard approach many athletes use involves a “loading phase” of higher doses for the first week, followed by a lower daily maintenance dose. A preprint study examining gastrointestinal side effects found that participants using a loading dose reported more stomach discomfort and bloating than those starting with a standard dose, though the differences were not statistically significant.¹⁰ If you already deal with the gastrointestinal quirks that diabetes and its medications can bring, skipping the loading phase and starting with a lower daily dose may be more comfortable. Muscle creatine stores will still saturate, just more slowly.

Creatine pulls water into muscle cells, which can cause mild weight gain from fluid retention in the first week or two. This is not fat gain, but if you are tracking your weight closely as part of diabetes management, be aware the scale may move a couple of pounds. Hydration matters more than usual during supplementation for this reason.

Tell your doctor before starting creatine, especially if your kidney function is already being monitored. As discussed earlier, your serum creatinine levels will likely rise, and your doctor needs to know why so they do not mistake it for kidney deterioration. If you have existing kidney disease beyond what is typical for your diabetes, the safety data becomes much less clear because those patients were excluded from the trials.

Creatine and Fatty Liver Disease

Non-alcoholic fatty liver disease is extremely common in people with type 2 diabetes. The metabolic overlap between the two conditions means that anything a diabetic person takes should ideally not make liver problems worse. Animal research on creatine has produced an interesting split: creatine supplementation prevented the progression of fatty liver caused by a high-fat diet, reducing liver fat accumulation and markers of liver damage.¹¹ That is encouraging news for the type of fatty liver disease most diabetics face. However, the same study found that creatine worsened alcohol-related fatty liver, so the effect depends entirely on the cause of the liver problem.

Human data on creatine and liver disease are essentially nonexistent. A review examining creatine’s potential role in chronic liver disease noted that its benefits are only indirectly suggested by the animal models, and no human clinical trials have been conducted.¹² So while the animal data lean positive for the non-alcoholic variety of fatty liver, this is another area where the research has not caught up to the questions patients are asking.

The Mitochondrial Angle in Type 2 Diabetes

A recent study uncovered something unexpected about how creatine metabolism goes wrong in people with type 2 diabetes. In men with the condition, plasma creatine levels were elevated while the phosphocreatine stored inside muscle cells was reduced. This imbalance was tied to lower expression of an enzyme called mitochondrial creatine kinase 2, which is responsible for shuttling energy within the cell’s powerhouses.¹³ The finding suggests that the creatine-energy system inside muscle is already disrupted in diabetes, independent of insulin signaling.

This is still early-stage research, but it raises an interesting question. If diabetic muscles are less efficient at using the creatine they already have, would supplying more creatine from outside help compensate, or would it just accumulate without benefit? The answer is not yet clear, but it adds a layer of nuance to the GLUT-4 mechanism described earlier. Creatine supplementation in diabetes may not just be about getting more glucose into cells. It may also be about restoring a broken energy-recycling system within those cells, though whether supplementation actually accomplishes that has not been tested directly.

Type 1 Versus Type 2 Diabetes

Nearly all the creatine-and-diabetes research has focused on type 2 diabetes. If you have type 1 diabetes, the safety and metabolic effects of creatine have not been specifically studied in clinical trials for your condition. The mechanisms are quite different: type 1 diabetes involves the immune system destroying insulin-producing cells, while type 2 involves insulin resistance. Creatine’s potential glucose-lowering effects seem to work through improved glucose transport into muscle, which is more directly relevant to the insulin resistance seen in type 2. That does not mean creatine is unsafe for people with type 1, but it does mean the evidence base simply is not there yet. Any person with type 1 diabetes considering creatine should approach it as an open question and discuss it with their care team.

Similarly, people with diabetic kidney disease beyond mild impairment were excluded from the trials that established creatine’s kidney safety. If your estimated GFR is already significantly reduced, the reassuring data from the existing trials may not apply to you. The trials specifically enrolled diabetic patients whose kidneys were still functioning reasonably well. Extrapolating to more advanced kidney disease is not something the current evidence supports.